Literature DB >> 20298185

Cellular origin of Barrett's metaplasia and oesophageal stem cells.

Mariagnese Barbera1, Rebecca C Fitzgerald.   

Abstract

Barrett's oesophagus is a metaplastic pre-malignant disorder and the only established precursor lesion for oesophageal adenocarcinoma. Barrett's oesophagus develops when the normal stratified squamous epithelium of the lower oesophagus is replaced by a columnar lined mucosa with intestinal differentiation, usually in the context of chronic gastro-oesophageal reflux disease. The cellular and molecular mechanisms by which this metaplastic transformation occurs are poorly understood. Abnormal differentiation of multipotent stem cells in the squamous oesophagus, triggered by exposure to refluxate, is one potential mechanism. These stem cells could be located in the basal layer of the squamous oesophageal epithelium and/or in the neck region of the oesophageal submucosal gland ducts; however, their exact location and identification are still matter of discussion. Three-dimensional models combined with state-of-the-art imaging techniques are now applied to characterize the squamous epithelium in human oesophageal samples, and this could unveil essential information to identify these progenitor cells. Locating stem cells in human squamous oesophagus could have important implications for our understanding of Barrett's oesophagus and remarkably improve our future strategies for its prevention.

Entities:  

Mesh:

Year:  2010        PMID: 20298185     DOI: 10.1042/BST0380370

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  12 in total

1.  Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.

Authors:  Michael Quante; Govind Bhagat; Julian A Abrams; Frederic Marache; Pamela Good; Michele D Lee; Yoomi Lee; Richard Friedman; Samuel Asfaha; Zinaida Dubeykovskaya; Umar Mahmood; Jose-Luiz Figueiredo; Jan Kitajewski; Carrie Shawber; Charles J Lightdale; Anil K Rustgi; Timothy C Wang
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

Review 2.  Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katherine S Garman; Roy C Orlando; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

3.  Activin A-mediated epithelial de-differentiation contributes to injury repair in an in vitro gastrointestinal reflux model.

Authors:  Cedric Roudebush; Alma Catala-Valentin; Thomas Andl; Gregoire F Le Bras; Claudia D Andl
Journal:  Cytokine       Date:  2019-07-29       Impact factor: 3.861

4.  Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Kenneth J Vega; Randal May; Sripathi M Sureban; Stan A Lightfoot; Dongfeng Qu; Alessandra Reed; Nathaniel Weygant; Rama Ramanujam; Rhonda Souza; Mohammad Madhoun; Joshua Whorton; Shrikant Anant; Stephen J Meltzer; Courtney W Houchen
Journal:  J Gastroenterol Hepatol       Date:  2012-04       Impact factor: 4.029

Review 5.  Barrett esophagus: what a mouse model can teach us about human disease.

Authors:  Michael Quante; Julian A Abrams; Yoomi Lee; Timothy C Wang
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

6.  Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens.

Authors:  Stephen J Hayes; Keng Ngee Hng; Peter Clark; Fiona Thistlethwaite; Robert E Hawkins; Yeng Ang
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

7.  Do transcription factors hold the key to understanding the development of Barrett's esophagus?

Authors:  Rebecca C Fitzgerald
Journal:  Dig Dis Sci       Date:  2012-02-25       Impact factor: 3.199

Review 8.  Epithelial cell plasticity: breaking boundaries and changing landscapes.

Authors:  Aleksandra Tata; Ryan D Chow; Purushothama Rao Tata
Journal:  EMBO Rep       Date:  2021-06-06       Impact factor: 9.071

9.  Cardiomyocyte marker expression in mouse embryonic fibroblasts by cell-free cardiomyocyte extract and epigenetic manipulation.

Authors:  Tahereh Talaei-Khozani; Fatemeh Heidari; Tahereh Esmaeilpour; Zahra Vojdani; Zohrah Mostafavi-Pour; Leili Rohani
Journal:  Iran J Med Sci       Date:  2014-03

10.  IL-1RT1 signaling antagonizes IL-11 induced STAT3 dependent cardiac and antral stomach tumor development through myeloid cell enrichment.

Authors:  Jon N Buzzelli; Dan I Pavlic; Heather V Chalinor; Louise O'Connor; Trevelyan R Menheniott; Andrew S Giraud; Louise M Judd
Journal:  Oncotarget       Date:  2015-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.